Information, Expiry & Status of Health Canada Patents covering Bimatoprost.

U.S.A

Bimatoprost

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

Patent Number

2144967

Strength per Unit

0.01%

Dosage Form

Ophthalmic Solution

Human Or VET

Human

Patent Expiration Date

2013-09-09

Date Granted

2003-11-11

Filing Date

1993-09-09

Brand Name

LUMIGAN RC

Route of Administration

Topical Ophthalmic

Iran Expo

Not Confirmed

Contact Supplier

Allergan Inc.

U.S.A

Bimatoprost

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

Patent Number

2144967

Strength per Unit

0.03%

Dosage Form

Ophthalmic Solution

Human Or VET

Human

Patent Expiration Date

2013-09-09

Date Granted

2003-11-11

Filing Date

1993-09-09

Brand Name

LUMIGAN RC

Route of Administration

Topical Ophthalmic

Iran Expo

Not Confirmed

Contact Supplier

Allergan Inc.

U.S.A

Bimatoprost

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

Patent Number

2585691

Strength per Unit

0.01%

Dosage Form

Ophthalmic Solution

Human Or VET

Human

Patent Expiration Date

2026-03-14

Date Granted

2009-05-19

Filing Date

2006-03-14

Brand Name

LUMIGAN RC

Route of Administration

Topical Ophthalmic

Iran Expo

Not Confirmed

Contact Supplier

Allergan Inc.

U.S.A

Bimatoprost

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

Patent Number

2144967

Strength per Unit

0.03% w / v

Dosage Form

Ophthalmic Solution

Human Or VET

Human

Patent Expiration Date

2013-09-09

Date Granted

2003-11-11

Filing Date

1993-09-09

Brand Name

LUMIGAN PF

Route of Administration

Topical Ophthalmic

Iran Expo

Not Confirmed

Contact Supplier

Allergan Inc.

U.S.A

Bimatoprost

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

Patent Number

2401731

Strength per Unit

0.03%

Dosage Form

Sterile Solution

Human Or VET

Human

Patent Expiration Date

2021-03-30

Date Granted

2007-05-29

Filing Date

2001-03-30

Brand Name

LATISSE

Route of Administration

Topical

Iran Expo

Not Confirmed

Contact Supplier

Allergan Inc.

U.S.A

Bimatoprost

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

Patent Number

2144967

Strength per Unit

0.03%

Dosage Form

Sterile Solution

Human Or VET

Human

Patent Expiration Date

2013-09-09

Date Granted

2003-11-11

Filing Date

1993-09-09

Brand Name

LATISSE

Route of Administration

Topical

Iran Expo

Not Confirmed

Contact Supplier

Allergan Inc.

U.S.A

Bimatoprost